logo

Chemomab Therapeutics Ltd. (CMMB)



Trade CMMB now with
  Date
  Headline
11/12/2021 7:05:45 AM Amended: Chemomab Therapeutics Q3 Net Loss $2.97 Mln Vs Net Loss $1.22 Mln Last Year
11/8/2021 7:16:18 AM Chemomab Therapeutics Names Donald Marvin CFO, EVP And COO
9/27/2021 7:21:10 AM Chemomab Therapeutics Collaborates With Leeds University To Further Study The Role Of CCL24
9/2/2021 7:02:37 AM Chemomab Therapeutics Appoints Dale Pfost As CEO
8/13/2021 8:07:14 AM Chemomab Therapeutics Q2 Loss $2.8 Mln Or $0.01/shr Vs. Loss $1.1 Mln Or $0.01/shr Prior Year
6/23/2021 8:34:53 AM Chemomab Therapeutics, AGC Biologics Expand Partnership To Manufacture CM-101 To Support Phase II/III Clinical Testing
4/26/2021 6:35:12 AM Chemomab Enrolls First Patient In Phase 2a Study Of CM-101 In Non-Alcoholic Steatohepatitis